4//SEC Filing
Jenne Kyle 4
Accession 0000874015-25-000061
CIK 0000874015other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 7:40 PM ET
Size
8.7 KB
Accession
0000874015-25-000061
Insider Transaction Report
Form 4
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
Transactions
- Award
Restricted Stock Unit
2025-01-15+28,050→ 28,050 totalExercise: $0.00From: 2026-01-15→ Common Stock (28,050 underlying) - Award
Performance Restricted Stock Units
2025-01-15+18,700→ 18,700 totalExercise: $0.00From: 2028-01-15→ Common Stock (18,700 underlying)
Footnotes (5)
- [F1]Grant to reporting person of Performance Restricted Stock Units (PRSUs) under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
- [F2]The PRSUs may vest at the end of the three-year performance period following the date of grant based on the Issuer's relative total shareholder return as compared to a peer group of companies. The number of PRSUs reported represents the maximum that may be earned, which is 200% of the target number. No number of PRSUs is guaranteed to vest and the actual number of PRSUs that will vest at the end of the performance period may be anywhere from zero to the amount stated.
- [F3]Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
- [F4]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F5]Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001791857
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 7:40 PM ET
- Size
- 8.7 KB